Benzinga | Aug 10, 2020 04:23PM EDT

AcelRx Pharmaceuticals Q2 EPS $(0.08) Beats $(0.14) Estimate, Sales $2.92M Beat $2.02M Estimate

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.14) by 42.86 percent. This is a 50 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $2.92 million which beat the analyst consensus estimate of $2.02 million by 44.75 percent. This is a 210.73 percent increase over sales of $941.00 thousand the same period last year.